by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Prevention, Treatment as Prevention |
CROI 2014: Jens Lundgren
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Microbicides, Prevention |
CROI 2014: Microbicides Two prominent members from AVAC’s Global Advocacy for HIV Prevention team expound on the paradigm shift that is occurring around the nomenclature for ‘long lasting’ treatments. New options for HIV prevention exist and are in...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Prevention |
CROI 2014: The Science of PrEP There is to date one approved oral Pre-Exposure Prophylaxis antiretroviral medication that can prevent HIV infection if taken regularly. Alternatives in development presented at CROI include topical agents, injectable agents, and...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Prevention, Treatment as Prevention |
CROI 2014: Prevention A panel discussion reviewing the most interesting prevention conversations at this years 21st CROI conference. Of note the panel identifies adherence to be the main issue with the one pill a day versions of PrEP. Questions about inconsistent...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Prevention |
CROI 2014: PrEP – Use It Or Lose It A recap of the PREP — Use It Or Lose It presentation held at CROI. The panel particularly looks at how the once a day prevention pill use can affect communities of color, and youth. PrEP has been shown to be protective...
by Jim Thompson | Mar 12, 2013 | Advocacy, Aging, Antiretrovirals, Blog, Co-infection, CROI, CROI 2013, Cure, Global, Italian, Prevention, Research, Treatment as Prevention, Vaccine |
Massimo Andreoni, MD is a Professor Infectious Diseases, University of Antwerp. Andrea Antinori, MD, is a clinician with the Istituto Nazionale per le Malattie Infettive and a member of Nadir Onlus. ยท Giovanni di Perri, MD, PhD is Professor of Infectious Diseases at...
